DBVTF
DBV Technologies S.A.
$4.26
0.00%
No data for this timeframe.
Vol
SEC Reports2
Exchange OTC·Sector Biological Products, (No Diagnostic Substances)·Inc. I0·CIK 0001613780·Prev Close $4.26
Recent Activity
Jun 5, 2026
SEC
DBV Technologies granted CEO Daniel Tass 4,060,000 performance share units (PSUs) tied to FDA approval of Viaskin Peanut
8-K — Impact 2/10
Apr 30, 2026
SEC
DBV Technologies reported Q1 2026 financial results, showing a net loss of $47.6M, widening from $27.1M in Q1 2025, driv
8-K — Impact 4/10
Analyst Ratings
3Strong Buy
3Buy
1Hold
1Sell
0Strong Sell
Latest Reports
NEUTRAL
8-K
2/10
DBV Technologies granted CEO Daniel Tass 4,060,000 performance share units (PSUs) tied to FDA approval of Viaskin Peanut
Jun 5, 2026
NEUTRAL
8-K
4/10
DBV Technologies reported Q1 2026 financial results, showing a net loss of $47.6M, widening from $27.1M in Q1 2025, driv
Apr 30, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
2 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 2 neutral. Avg impact: 3.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 75% buy across 8 analysts — 3 strong buy, 3 buy, 1 hold, 1 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | -47.8% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | -72.2% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | -23.9% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | 2025.9% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 3 | 3 | 1 | 1 | 0 | 75% | |
| May 1, 2026 | 3 | 3 | 1 | 1 | 0 | 75% | |
| Apr 1, 2026 | 3 | 3 | 1 | 1 | 0 | 75% | |
| Mar 1, 2026 | 3 | 3 | 1 | 1 | 0 | 75% | |
| Feb 1, 2026 | 3 | 3 | 1 | 1 | 0 | 75% | |
| Jan 1, 2026 | 3 | 3 | 1 | 1 | 0 | 75% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.